ask="N/A"
ask_size="N/A"
average_daily_volume="156174"
bid="12.26"
bid_size="400"
book_value="6.55"
change="-0.05"
change_from_200_day_moving_average="0.62"
change_from_50_day_moving_average="-0.46"
change_from_52_week_high="-7.08"
change_From_52_week_low="4.10"
change_in_percent="-0.31%"
close="16.12"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.68"
ebitda="-63.46M"
eps_estimate_current_year="-3.02"
eps_estimate_next_quarter="-0.73"
eps_estimate_next_year="-3.05"
ex_dividend_date="N/A"
float_shares="11787000"
high="16.82"
high_52_weeks="23.20"
last_trade_date="1/23/2017"
last_trade_price="16.12"
last_trade_size="8656"
last_trade_time="4:00pm"
low="16.06"
low_52_weeks="12.02"
market_capitalization="354.35M"
moving_average_200_day="15.50"
moving_average_50_day="16.58"
name="Adamas Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="30.67"
open="16.17"
pe_ratio="N/A"
peg_ratio="-0.07"
percent_change_from_200_day_moving_average="+3.99%"
percent_change_from_50_day_moving_average="-2.79%"
percent_change_from_52_week_high="-30.52%"
percent_change_from_52_week_low="+34.11%"
previous_close="16.17"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.47"
price_per_sales="335.65"
revenue="1.06M"
shares_outstanding="21982000"
short_ratio="27.37"
stock_exchange="NGM"
symbol="ADMS"
volume="79947"
weeks_range_52="12.02 - 23.20"
